Breast Cancer Trial, Recruiting NCT06582615 Sponsor: Ohio State University Comprehensive Cancer Center Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06582615
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 40 and 65 years old
  • Women who have been diagnosed with stage I, II, or III triple negative breast cancer (a specific type of breast cancer)
  • People who started their first cancer treatment (such as chemotherapy, targeted therapy, or immunotherapy) for this type of breast cancer no more than 12 months ago
  • People who are able to access the internet and participate in video calls using the Zoom platform
  • People who speak English

Who may not be able to join:

  • People who have a history of dementia, stroke, traumatic brain injury, cancer that has spread to the brain, or other conditions that may affect memory or thinking
  • People who already follow a very healthy diet, as measured by a high score (above 12) on something called the MIND diet scoring system
  • People who are unwilling or unable to eat more than two types of food that are part of the MIND diet — for example, if someone avoids more than two food categories such as leafy green vegetables, olive oil, or non-fried fish
  • People who are currently pregnant
  • People who are not able to give informed consent to participate in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tonya Orchard, PhD, Ohio State University Comprehensive Cancer Center

Phone: 800-293-5066

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ohio State University Comprehensive Cancer Center
Registry
ClinicalTrials.gov
Start date
28 October 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in Wechsler Adult Intelligence Scale, fourth edition (WAIS-IV) Digit Span score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov